
Home » Pipeline
Pipeline
Company | Drug/Device | Medical Condition | Status |
---|---|---|---|
Immatics | IMA203 | solid tumors | Phase I trial initiated enrolling 15 subjects with relapsed and/or refractory solid tumors for which no standard of care therapy is available |
Concert Pharmaceuticals, Inc. | CTP-692 | schizophrenia | Phase I trial initiated |
National Institutes of Health (NIH) | H1ssF_3928 | flu | Phase I trial initiated |
Synchron, Inc. | Stentrode in combination with BrainOS software | severe paralysis | Phase I trial initiated taking place at hospitals in Melbourne, Australia |
Homology Medicines, Inc. | HMI-102 | phenylketonuria (PKU) | Phase I/II trial initiated enrolling adults aged 18 to 55 years |
NanOlogy | NanoDoce (sterile submicron particle docetaxel suspension) | bladder cancer | Phase I/II trial initiated |
Provention Bio, Inc. | PRV-031 (teplizumab) | recent onset type 1 diabetes (T1D) | Phase III trial initiated enrolling 300 subjects aged 8-17 years with recent onset T1D at 80 centers worldwide |
Pfizer | IBRANCE (palbociclib) | men with HR+, HER2- metastatic breast cancer | sNDA approval granted by the FDA |
Synspira Therapeutics | SNSP113 | cystic fibrosis (CF) | Orphan Drug designation granted by the EMA |
Aggredyne, Inc. | AggreGuide A 100 ADP Assay testing cartridge | platelet testing technologies | Clearance granted by the FDA |
Spry Health | Loop System | chronic obstructive pulmonary disease (COPD) | Clearance granted by the FDA |
Viiv Healthcare | Dovato (combination of dolutegravir (DTG) and lamivudine (3TC)) | HIV-1 in adults who had not received treatment before | Approval granted by the FDA |
Amgen | Evenity (romosozumab-aqqg) | osteoporosis in postmenopausal women at high risk of breaking a bone (fracture) | Approval granted by the FDA |
Upcoming Events
-
05Dec
-
14Apr